Almac Group
The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Our innovative services range from R&D, biomarker discovery, development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture. The international company is a privately owned organisation that has grown organically over the past five decades now employing over 5,600 highly skilled personnel across 18 facilities including Europe, the US and Asia. Click here to view our facilities. We have a global reputation for excellence built over 50 years of client service, initially as Galen and then as the wider Almac Group including Galen, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.
Company details
Find locations served, office locations
- Business Type:
- Service provider
- Industry Type:
- Clinical Services
- Market Focus:
- Globally (various continents)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
Almac Diagnostic Services is a stratified medicine company specialising in biomarker driven clinical trials.
The company, based in Craigavon, UK and Durham, USA has been in existence for over 15 years.
The Almac Diagnostic Services leadership team have worked on many key projects together for over a decade, in partnership with global pharma and biotech clients. Our senior leadership team is also extremely well networked within industry and academia.
As part of the wider Almac Group, we are a stable, privately owned business that is growing globally in line with increased customer demand.
Our diagnostic experience spans:
- Oncology
- Immunology
- CNS
- Infective diseases
Our History
Almac Diagnostic Services has been trading for over 15 years and was initially founded as a spin out company from Queen’s University Belfast in 2002 called ArraDx.
In 2004, ArraDx was incorporated into the Almac Group under the direction of Sir Allen McClay and became Almac Diagnostic Services. It was a vision of the Almac Group to have a Diagnostics division to support the growing need for Diagnostic services and to enable the delivery of precision medicine globally.
Since that time Almac Diagnostic Services has continued to grow and evolve as a business focussed on stratified medicine and complex diagnostic and companion diagnostic tests.
In terms of Regulatory Standards, Almac Diagnostic Services has held CLIA Lab Accreditation since 2011 and CAP Accreditation since 2012. We also received our New York State Permit (CLEP) in 2013. We were also awarded several other US State permits between 2011 and 2016 including Pennsylvania, California, Florida, Maryland and Rhode Island.
In terms of Quality ISO certification Almac Diagnostic Services was awarded ISO 17025 in 2005, ISO 13485 in 2015 and ISO 15189 in 2017.
Almac Diagnostic Services expanded laboratory capabilities by setting up a new laboratory in Durham, North Carolina, USA, in 2016. We continue to expand our range of platform options for clients and have strong partnership agreements in place with key providers for significant periods of time, including Illumina, Thermo Fisher, Nanostring and Qiagen.
Almac Diagnostic’s growth trajectory aligns with increasing global demand for our offering. We continue to expand our range of services to Pharma and Biotech clients and add to our own internal R&D assay pipeline. We have won several awards along the way for our science and innovation capabilities. Most notably the UKTI Award for Innovation as part of the European Business Awards, the ‘R&D Development Achievement Award’ for our DDRD Assay as part of the Irish Pharma Industry Awards and finally the ‘Excellence in Technology’ award as part of the Belfast Telegraph Business Awards.
Almac Diagnostic Services flexible approach has attracted many successful Companion Diagnostic (CDx) partnerships over the years and we look forward to the future by increasing our partnerships with Pharma and Biotech companies globally.
Our Culture
Almac Diagnostic Services has been trading for over 15 years. The culture we have built is very much one of openness, collaboration, fairness and respect where our employees are empowered to be innovative and to create and deliver customised companion diagnostic solutions for our clients.
It is a fast paced, exciting environment in which to work where individuals are recognised for their contribution to the company’s overall success. We are proud to have a diverse mix of professionals from many countries and differing scientific and non-scientific backgrounds who all combine together to deliver world class solutions every day.
We are all driven towards a common goal to help our Pharma and Biotech partners differentiate and deliver their drug to the marketplace, ultimately assisting in better personalised medicine decisions and better patient outcomes, both now and in the future.
Almac Diagnostic Services is built on the foundations laid by the core values of the Almac Group and we are always looking for people who share the same standards that have made Almac the success that it is today.
Working at Almac Diagnostic Services offers many possibilities for career fulfilment and career progression.
What we are looking for- Inspirational People
- Exceptional Quality
- Superlative Customer Focus
- Outstanding Innovation
- Financial Stability
Almac Diagnostic Services is a stratified medicine company focused on the discovery, development, and commercialisation of complex diagnostic tests including companion diagnostics.